OncologyNurseAdvisor

#AcceptanceAndCommitmentTherapy provided benefits such as improving symptoms of depression and anxiety, as well as contributing to psychological flexibility and hope, for patients with #cancer. With @cancernurseEU. bit.ly/4tc7qRX #ACT #CancerCare

Naldemedine, a peripherally acting μ-opioid receptor antagonist used to prevent opioid-induced constipation, also prevented opioid-induced nausea and vomiting in patients receiving opioids for #cancerpain. Published in @OncJournal. bit.ly/4uOjNoP #Opioids

A digital status board in the #infusion center waiting room improved communication about appointment status and #patientSatisfaction. bit.ly/4v1vysa

Our appreciation to @ONAcom for providing in-depth trial coverage in the article: Skin Fluorescence Imaging Accurately Flags High-Risk Melanocytic Lesions. We are honored that Dermatology Daily also cited the study as headline news on February 13, 2026. oncologynurseadvisor.com/news/melanoma-…

Study identifies distinct age-based symptom burden profiles in #oncologyOutpatients. Psychological symptoms define younger subgroups, while disengagement coping marks high-burden older adults. From @CancerMedicineJ. Read the review: bit.ly/3PURgOb #CancerCare

In #NMIBC, immediate administration of 2 doses of neoadjuvant intravesical mitomycin C chemotherapy prior to TURBT may reduce recurrence and progression risks compared with TURBT alone. From @renalandurology. bit.ly/41gINY2 #blcsm #bladdercancer

Timely, developmentally tailored diagnostic disclosure may reduce anxiety and strengthen coping among school-aged children with acute #lymphoblasticLeukemia. Published in @PECthejournal. bit.ly/3PlZRt5 #ALL #leusm

Despite widespread endorsement of #sharedDecisionMaking, no published study has explicitly aimed to measure the burden of SDM, and no validated instrument exists to assess this construct directly. Published in @PECthejournal. bit.ly/47evomR #CancerCare

@NCCN guidelines define #cancer-related distress as a multifactorial experience impacting 30–47% of patients. Unresolved distress correlates with nonadherence to therapy and increased #medicalcosts. 📊 Read the review here: ➡️ bit.ly/4spYxUS

A relational model of care facilitates meaningful living for patients during #endofLife treatment. Nurses utilize presence and dialogue to address existential concerns and improve quality of life. 🩺 Read the review: bit.ly/4rA6nd7 #MedEd #PalliativeCare

A majority of older patients with #advancedcancer have indicated they prioritize quality of life over extending survival. Published by @JAMAOnc and @CancerTherAdvsr. bit.ly/4diCYk4 #QOL #cancercare

The @FDA has approved teclistamab in combo with daratumumab hyaluronidase-fihj for adult patients with R/R #multipleMyeloma who have received at least 1 prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent. From @eMPR. bit.ly/4rtYpCe

Experience the 2026 ONA Summit—now 4 days away! Free live virtual #CE event for #Oncology nurses in all roles. Gain state-of-the science strategies from leading experts March 20-21. Register now! bit.ly/4qjckL5

Combined neoadjuvant treatment with ipilimumab and nivolumab followed by CRT shows promise as a bladder-sparing treatment for muscle-invasive #bladdercancer. From @NatureMedicine and @renalandurology. Read more: ➡️ bit.ly/3MZPjiH #MIBC #blcsm #UroOnc

#ColorectalCancer is now the leading cause of cancer-related deaths among adults aged younger than 50 years. Experts warn of contributing factors. bit.ly/4sIX0cc #ColorectalCancerAwarenessMonth #CCAM

#CancerMortality decreases with higher moderate to vigorous #physicalActivity levels across diagnoses. Published in @JAMANetworkOpen. bit.ly/4ba179O #CancerPrevention

#PsoasMuscleDensity declined more in patients receiving ICIs. Published in @OncJournal. bit.ly/4rtsQIO #skcsm

The multidisciplinary team model was determined to be an essential component of providing patient-centered, personalized care for WDTC. Published in @OncJournal. bit.ly/4sBEemX #thyroidCarcinoma

Ensure you are current with the latest best practices in #Oncology nursing. Attend the free live virtual ONA Summit March 20-21 and earn free #CE. Click here to secure your space today! bit.ly/4qjckL5

Venetoclax plus obinutuzumab yields comparable efficacy in both fit and unfit #CLL patients. 3-year PFS reached 81.9% and 75.3%, respectively (P=.09). 🧪 From @HematologyAdv. Read the review: bit.ly/4cvVQvQ #leusm